# Influence of Albumin on Acute Renal Dysfunction Associated With Cardiac Surgery Under Extracorporeal Circulation

> **NCT03373318** · PHASE4 · UNKNOWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 250 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Human albumin
- **DRUG:** Plasmalyte

## Key facts

- **NCT ID:** NCT03373318
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-10
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03373318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03373318, "Influence of Albumin on Acute Renal Dysfunction Associated With Cardiac Surgery Under Extracorporeal Circulation". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03373318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*